Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,765.60
(
-1.52%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.88
(
7.18%
)
Bitcoin
71,323.92
(
-3.54%
)
News Focus
News Focus
Post# of 257255
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122794
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 67794

Friday, 07/10/2009 8:07:43 AM

Friday, July 10, 2009 8:07:43 AM

Post# of 257255
MRK – The FDA just approved a label expansion of Isentress into the first-line HIV setting based on phase-3 head-to-head data vs Sustiva reported last October: #msg-33123339. This approval was never in doubt—so much so that MRK has not even bothered to issue a PR!


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now